Acetaminophen tablets recalled for incorrect imprinting
Akron Pharma is recalling Acetaminophen Regular Strength 325 mg tablets due to incorrect imprinting on the tablets. The recall involves approximately 6,429 bottles distributed nationwide.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: FDA Class III recall for a labeling and identification issue with no reported illnesses or injuries, making this a low-risk precautionary recall.
Plain-English summary
Akron Pharma, Inc. is recalling Acetaminophen Regular Strength tablets, 325 mg, in bottles of 100 tablets. The tablets are imprinted with incorrect identification. The affected product is lot number KDT0124001 with an expiration date of August 31, 2026, NDC number 71399-8024-01.
Approximately 6,429 bottles were distributed nationwide throughout the United States. This is a Class III recall issued by the U.S. Food and Drug Administration.
The recalled product
- Product
- Acetaminophen Regular Strength, 325 mg, 100 Tablets per bottle, Akron Pharma, Inc., 373 RT US 46 W Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8024-01 .
- Manufacturer
- Akron Pharma, Inc.
- Category
- Drug
- Hazard
- mis-labeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: KDT0124001
- Exp 08/31/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27